31608 Tirzepatide for Sale
Compare supplier listings for Tirzepatide (CAS 2023788-19-2) — check price, grade and packaging, then open a product page or send an inquiry. View Suppliers
Tirzepatide cas 2023788-19-2 powder 99% purity 15mg 30mg 40mg 50mg vials Peptides
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
15mg/vial, 10vials/box
GLP-1,trizepatide,Semaglutide,Retatrutide
Tirzepatide Powder 99.9% Peptide Weight Loss powder for export CAS NO: 2023788-19-2
-
Price:
$65/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
15mg/vial, 10vials/box
GLP-1,trizepatide,Semaglutide,Retatrutide
Tirzepatide 99% White powder cas 2023788-19-2 High Quality Pharmaceutical Grade raw Peptide for weight loss
-
Price:
$1/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
50g 1kg
GLP-1,trizepatide,Semaglutide,Retatrutide
Tirzepatide Powder 99.9% Peptide CAS: 2023788-19-2 Weight Loss powder for export
-
Price:
$60/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
15mg/vial, 10vials/box
GLP-1,trizepatide,Semaglutide,Retatrutide
High Purity 99% Tirzepatide Retatrutide Peptide Freeze Dried Powder Weight Loss Peptide GLP 1 Peptide
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/vial, 10vials/box
GLP-1,trizepatide,Semaglutide,Retatrutide
Products You May Be Interested in
Customizable 99% Purity GLP-1 Weight Loss Peptides: Retatrutide (CAS 2381089-83-2), Tirzepatide on Sale
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/vial,10vials/box
GLP-1,trizepatide,Semaglutide,Retatrutide
99% Purity GLP-1 Tirz Peptide (5/10/15/20/30mg) & Retatrutide 15mg Lyophilized Powder Safe Delivery for Weight Loss
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/vial,10vials/box
GLP-1,trizepatide,Semaglutide,Retatrutide
99% High Quality Tirzepatide Grade:Pharmacy Grade Packaging:15mg/vial, 10vials/box CAS No.:2023788-19-2
-
Price:
$65/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
15mg/vial, 10vials/box
GLP-1,trizepatide,Semaglutide,Retatrutide
Hot Selling 99% High Quality Tirzepatide CAS No.:2023788-19-2 Grade:Pharmacy Grade Packaging:15mg/vial, 10vials/box
-
Price:
$65/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
15mg/vial, 10vials/box
GLP-1,trizepatide,Semaglutide,Retatrutide
High Quality Tirzepatide Powder CAS: 2023788-19-2 99.9% Peptide Fitness and Weight Loss
-
Price:
$60/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
15mg/vial, 10vials/box
GLP-1,trizepatide,Semaglutide,Retatrutide
- Buying Tirzepatide on www.echemi.com where you will find large variety of good choices. Suppliers of 31608 Tirzepatide registered will be verified by the accurate information. Safe transaction of chemical will be made based on true information. We help you get chemicals in need continuously and meet registered Tirzepatide suppliers.
- The quality of Tirzepatide 2023788-19-2 will be secured by ECHEMI. The pursuit of high quality requires all partners of ECHEMI to be screened, whether its certificate, qualification or scale. Tirzepatide will reach global regulation and requirement of various regions. Further services on the whole supply chain can be provided with ECHEMI.
- We offer reasonable and fair market price of Tirzepatide to provide better products and services. Services of Tirzepatide like trade data and market price and insight can be subscribed on ECHEMI. You can enjoy the chemical supply chain services on ECHEMI. We will help you purchase Tirzepatide and run fast your business.
- •China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
- •Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
- •Novo Nordisk’s Semaglutide Faces Strong Competition: Eli Lilly’s Tirzepatide Officially Launched in China
- •Eli Lilly Revenue Reaches $31.5 Billion, Up 27%! Tirzepatide and Semaglutide Exceed $20 Billion
- •Novo Nordisk's 2024 Earnings Surge by 23%! Diabetes Drug Sales Skyrocket, but Facing Competition Pressure from Tirzepatide